NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease
Authors:
- Daniel MartinezDMDaniel Martinez
- Alba NavarroANAlba Navarro
- Alejandra Martinez-TrillosAMAlejandra Martinez-Trillos
- Ricardo Molina-UrraRMRicardo Molina-Urra
- Blanca Gonzalez-FarreBGBlanca Gonzalez-Farre
- Itziar SalaverriaISItziar Salaverria
- Ferran NadeuFNFerran Nadeu
- Anna EnjuanesAEAnna Enjuanes
- Guillem ClotGCGuillem Clot
- Dolors CostaDCDolors Costa
- Ana CarrioACAna Carrio
- Neus VillamorNVNeus Villamor
- 1 February 2016
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 40 (2) , 192-201
Abstract
Splenic diffuse red pulp small B-cell lymphoma (SDRPL) is considered an indolent neoplasm and its pathogenesis is not well known. We investigated the molecular characteristics of 19 SDRPL patients, 5 of them with progressive disease. IGHV genes were mutated in 9/13 (69%). Cytogenetic and molecular studies identified complex karyotypes in 2 cases, and IGH rearrangements in 3, with PAX5 and potentially TCL1 as partners in each one of them. Copy number arrays showed aberrations in 69% of the tumors, including recurrent losses of 10q23, 14q31-q32, and 17p13 in 3, and 9p21 in 2 cases. Deletion of 7q31.3-q32.3 was present in only 1 case and no trisomies 3 or 18 were detected. NOTCH1 and MAP2K1 were mutated in 2 cases each, whereas BRAF, TP53, and SF3B1 were mutated each in single cases. No mutations were found in NOTCH2 or MYD88. Four of the 5 patients with aggressive disease had mutations in NOTCH1 (2 cases), TP53 (1 case), and MAP2K1 (1 case). The progression-free survival of patients with mutated genes was significantly shorter than in the unmutated (P=0.011). These findings show that SDRPL share some mutated genes but not chromosomal alterations, with other splenic lymphomas, that may confer a more aggressive behavior.Keywords
This publication has 34 references indexed in Scilit:
- Landscape of somatic mutations and clonal evolution in mantle cell lymphomaProceedings of the National Academy of Sciences, 2013
- Clonal Evolution, Genomic Drivers, and Effects of Therapy in Chronic Lymphocytic LeukemiaClinical Cancer Research, 2013
- Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphomaJournal of Experimental Medicine, 2012
- The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone developmentJournal of Experimental Medicine, 2012
- Both variant and IGHV4-34–expressing hairy cell leukemia lack the BRAF V600E mutationBlood, 2012
- Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphomaBlood, 2012
- BRAFMutations in Hairy-Cell LeukemiaNew England Journal of Medicine, 2011
- Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activationJournal of Experimental Medicine, 2011
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemiaNature, 2011
- FISH Analysis for the Detection of Lymphoma-Associated Chromosomal Abnormalities in Routine Paraffin-Embedded TissueThe Journal of Molecular Diagnostics, 2006